Stewart, Tyler F.
Petrylak, Daniel P.
Article History
First Online: 11 June 2019
Competing interests
: D.P.P. declares grant support and/or consultant fees from Ada Cap (Advanced Accelerator Applications), Amgen, Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Clovis, Eli Lilly, Endocyte, Exelixis, Genentech, Incyte, Innocrin, Janssen, MedImmune, Merck, Novartis, Pfizer, Pharmacyclics, Progenics, Roche Laboratories, Sanofi Aventis, Seattle Genetics, and Urogen. T.F.S declares no competing interests.